Advice
Discontinuation of docetaxel (Taxotere)
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.
Medicine details
- Medicine name:
- docetaxel (Taxotere)
- SMC ID:
- 201/05
- Indication:
- Operable, node-positive breast cancer.
- Pharmaceutical company
- Sanofi-Aventis
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 10 October 2005
Additional notes
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.